Outcome of Percutaneous Coronary Intervention for Left Versus Non-left Main Coronary Artery in Acute Coronary

S M Mamun Iqbal1, A M Shafique2, Neuton Mondal1

  • 1Department of Cardiology, MH Samorita Hospital and Medical College, Dhaka, BGD.

Cureus
|October 3, 2025
PubMed

Insights

Patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) affecting the left main coronary artery (LMCA) face higher risks of adverse cardiovascular events, including myocardial infarction and repeat revascularization, compared to those with non-LMCA involvement.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Acute coronary syndromes (ACS) involving the left main coronary artery (LMCA) are linked to significant morbidity and mortality.
  • Percutaneous coronary intervention (PCI) is a key treatment for ACS.
  • Outcomes of PCI for LMCA-ACS require further investigation.

Purpose of the Study:

  • To compare long-term outcomes of PCI in patients with ACS affecting the LMCA versus those with non-LMCA involvement.
  • To evaluate the incidence of major adverse cardiovascular events (MACE) and secondary endpoints post-PCI.
  • To identify risk factors associated with LMCA involvement in ACS.

Main Methods:

  • An interventional study involving 101 patients with ACS who underwent PCI.
  • Patients were divided into two groups: LMCA involvement (n=51) and non-LMCA involvement (n=50).
  • Follow-up assessments at 3, 6, and 12 months monitored MACE, persistent symptoms, repeat revascularization, and stent thrombosis.

Main Results:

  • The LMCA group had a higher MACE rate (6%) compared to the non-LMCA group (2%) (p=0.013).
  • Myocardial infarction (MI) occurred in 4% of the LMCA group, with no events in the non-LMCA group.
  • Higher rates of persistent symptoms and repeat revascularization were observed in the LMCA group.

Conclusions:

  • ACS involving the LMCA is associated with significantly higher rates of adverse cardiovascular outcomes after PCI.
  • PCI for LMCA-ACS necessitates careful consideration due to increased risks of MI and repeat revascularization.
  • Further research is warranted to optimize PCI strategies for LMCA-ACS patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
804
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
577
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215